SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 39.01 |
Enterprise Value ($M) | 12.13 |
Book Value ($M) | -11.13 |
Book Value / Share | -0.27 |
Price / Book | -3.51 |
NCAV ($M) | -19.05 |
NCAV / Share | -0.46 |
Price / NCAV | -2.05 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.60 |
Return on Equity (ROE) | -1.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.23 |
Current Ratio | 3.23 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 34.14 |
Assets | 42.06 |
Liabilities | 53.18 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | HealthCap VII, L.P. | 8.20 | 0.00 | |
13G | AbbVie Biotechnology Ltd | 6.80 | ||
13G/A | Vanguard Group Inc | 3.89 | ||
13G/A | Longview Innovation Corp. | 6.70 | -6.29 | |
13D/A | Trustees Of The University Of Pennsylvania | 3.10 | -42.64 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
106,056 | 226,030 | 46.92 | |
28,842 | 91,851 | 31.40 | |
54,677 | 135,355 | 40.40 | |
27,254 | 182,476 | 14.94 | |
29,351 | 232,467 | 12.63 | |
(click for more detail) |
Similar Companies | |
---|---|
BIOR – Biora Therapeutics, Inc. | BTMD – biote Corp. |
CADL – Candel Therapeutics, Inc. | CGTX – Cognition Therapeutics, Inc. |
CHRS – Coherus BioSciences, Inc. |
Financial data and stock pages provided by
Fintel.io